Es gibt neue Hoffnung für einen HIV-Impfstoff
https://www.wired.com/story/hiv-vaccine-broadly-neutralizing-antibodies/
Es gibt neue Hoffnung für einen HIV-Impfstoff
https://www.wired.com/story/hiv-vaccine-broadly-neutralizing-antibodies/
1 Kommentar
By Emily Mullin
An experimental vaccine developed at Duke University triggered an elusive type of broadly neutralizing antibody in a small group of people enrolled in a 2019 clinical trial. The findings were published today in the scientific journal *Cell*.
“This is one of the most pivotal studies in the HIV vaccine field to date,” says Glenda Gray, an HIV expert and the president and CEO of the South African Medical Research Council, who was not involved in the study. “This is a scientific feat and gives the field great hope that one can construct an HIV vaccine regimen that directs the immune response along a path that is required for protection.”
Read the full story: [https://www.wired.com/story/hiv-vaccine-broadly-neutralizing-antibodies/](https://www.wired.com/story/hiv-vaccine-broadly-neutralizing-antibodies/)